Skip to main content

Advertisement

Log in

CYP1B1 and predisposition to breast cancer in Poland

  • Clinical Trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background

The CYP1B1 gene is a polymorphic member of the P450 gene family and is considered to be a candidate gene for cancers of various types.

Objective

We inquired whether four SNPs in the CYP1B1 gene, alone or in combination, might be associated with breast cancer risk in Poland.

Methods

We genotyped 2017 cases of breast cancer and 876 controls, for four SNPs in the CYP1B1 gene. Genotype and haplotype frequencies were compared in cases and controls.

Results

In combinations of the R48G, A119S and L432V SNPs, four of the eight CYP1B1 haplotypes were more common in controls than in cases and each of these appeared to have a significant protective effect. A large reduction in risk was observed for women who were homozygous for one of these four haplotypes (OR = 0.2; 95%; CI = 0.05–0.5; P = 0.001) compared to women who were homozygous for the most common haplotype. In contrast, women who were homozygous for the GTC haplotype were at increased risk (OR = 1.5; 95%; CI = 1.0–2.1; P = 0.03) compared to women with the most common haplotype.

Conclusions

The CYP1B1 gene appears to influence breast cancer susceptibility in Poland.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hayes CL, Spink DC, Spink BC et al (1996) 17β-Estradiol hydroxylation catalysed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 93:9776–9781

    Article  PubMed  CAS  Google Scholar 

  2. Spink DC, Eugster H, Lincoln II DW et al (1992) 17β-Estradiol hydroxylation catalysed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8, -tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch Biochem Biophys 293:342–348

    Article  PubMed  CAS  Google Scholar 

  3. Spink DC, Hayes CL, Young NR et al (1994) The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17β-estradiol 4-hydroxylase. J Steroid Biochem Mol Biol 51:251–258

    Article  PubMed  CAS  Google Scholar 

  4. Han X, Liehr JG (1994) DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens:hormone-induced free radical damage preceding renal malignancy. Carcinogenesis 15:997–1000

    Article  PubMed  CAS  Google Scholar 

  5. Chakravarti D, Mailander PC, Li KM et al (2001) Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene 20:7945–7953

    Article  PubMed  CAS  Google Scholar 

  6. Service RF (1998) New role for estrogen in cancer. Science 279:1631–1633

    Article  PubMed  CAS  Google Scholar 

  7. Jan ST, Devanesan PD, Stack DE et al (1998) Metabolic activation and formation of DNA adducts of hexestrol, a synthetic nonsteroidal carcinogenic estrogen. Chem Res Toxicol 11:412–419

    Article  PubMed  CAS  Google Scholar 

  8. Watanabe J, Shimada T, Gillam EM et al (2000) Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetic 10:25–33

    Article  CAS  Google Scholar 

  9. Gotoh O, Tagashira Y, Lizuka T et al (1983) Structural characteristic of cytochrome P450; possible location of the heme-binding cysteine in determined amino acid sequence. J Biochem 93:807–817

    PubMed  CAS  Google Scholar 

  10. Hanna IH, Dawling S, Roodi N, et al (2000) Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60:3440–3444

    PubMed  CAS  Google Scholar 

  11. Shimada T, Hayes CL, Yamazaki H et al (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 56:2979–2984

    PubMed  CAS  Google Scholar 

  12. Shimada T, Watanabe J, Kawajiri K et al (1999) Catalytic properties of polymorphic human cytochrome P4501B1 variants. Carcinogenesis 20:1607–1613

    Article  PubMed  CAS  Google Scholar 

  13. Rylander-Rudqvist T, Wedren S, Granath F et al (2003) Cytochrome P450 1B1 gene polymorphisms and post menopausal breast cancer risk. Carcinogenesis 24:1533–1539

    Article  PubMed  CAS  Google Scholar 

  14. Bailey LR, Roodi N, Dupont WD et al (1998) Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 58:5038–5041

    PubMed  CAS  Google Scholar 

  15. De Vivo I, Hankinson SE, Li L et al (2002) Association of CYP1B1 Polymorphisms and Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev 11:489–492

    PubMed  Google Scholar 

  16. Aksan H, Chen Y, Whittemore AS et al (2004) A family –based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Breast Cancer Res Treat 85:121–131

    Article  Google Scholar 

  17. Kocabas NA, Sardas S, Cholerton S et al (2002) Cytochrome P450 and catechol O-methyltransferase (COMT) genetic polymorphism and breast cancer susceptibility in a Turkish population. Arch Toxicol 76:643–649

    Article  PubMed  CAS  Google Scholar 

  18. Zheng W, Xie DW, Jin F et al (2000) Genetic Polymorphism of Cytochrome P450–1B1 and Risk of Breast Cancer. Cancer Epidemiol Biomarkers Prev 9:147–150

    PubMed  CAS  Google Scholar 

  19. Schaid DJ, Rowland CM, Tines DE et al (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425–434

    Article  PubMed  Google Scholar 

  20. Chang BL, Zheng SL, Isaacs SD et al (2003) Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer. British Journal of Cancer 89:1524–1529

    Article  PubMed  CAS  Google Scholar 

  21. Cicek MS, Liu X, Carey G et al (2005) Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressiveness. Cancer Epidemiol Biomarkers Prev 14:2173–2177

    Article  PubMed  CAS  Google Scholar 

  22. Wen W, Cai Q, Shu XO et al (2005) Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the Shanghai breast cancer study and meta-analysis. Cancer Epidemiol Biomarkers Prev 14:329–35

    Article  PubMed  CAS  Google Scholar 

  23. Gallicchio L, Berndt SI, McSorley MA et al (2006) Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease. BMC Cancer 6:173

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge the contributions of M. Bębenek, J. Bręborowicz, M. Chosia, B. Czeszyńska, R. Czajka, B. Dębniak, W. Domagała, I. Dziuba, M. Foszczyńska-Kłoda, L.Fudali, S. Gozdecka-Grodecka, S. Góźdź, E. Grzybowska, K. Gugała, O. Haus, H. Janiszewska, A. Karczewska, J. Kładny, R. Kordek, A. Kozak, B. Kozak-Klonowska, W. Kozłowski., K.Lamperska, D. Lange, A. Lenczewski, A. Mackiewicz, E. Marczyk, B.Mąka, T. Mierzwa, M. Morawiec, B. Musiatowicz, J. Mituś, S. Niepsuj, M. Posmyk, A. Rozmiarek, J. Ryś, J. Sir, J. Skręt, M. Stawicka, D.Sorokin, J.Sygut, C.Szczylik, M. Szwiec, D. Surdyka, M. Uciński, K. Urbański, P. Wandzel, B.Waśko, A. Witek, R.Wiśniowski, A. Wojnar, J. Woytoń, O. Zambrano in collection of patients and controls.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven Alexander Narod.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matyjasik, J., Cybulski, C., Masojć, B. et al. CYP1B1 and predisposition to breast cancer in Poland. Breast Cancer Res Treat 106, 383–388 (2007). https://doi.org/10.1007/s10549-007-9500-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-007-9500-4

Keywords

Navigation